Balázs Szigeti (@psybalazs) 's Twitter Profile
Balázs Szigeti

@psybalazs

Psychedelics | Placebo effect | Data science | Citizen science | DeSci | RWE
@UCSF's @TrPR_program, @Imperial_PRG and @psy_dao

ID: 1439553901917786117

calendar_today19-09-2021 11:36:18

2,2K Tweet

3,3K Followers

739 Following

Johns Hopkins Psychedelic Research Center (@jhpsychedelics) 's Twitter Profile Photo

CPCR is hiring a postdoc to manage the operation of clinical drug trials focused on the treatment of PTSD with psychedelic therapy. Read more below!

CPCR is hiring a postdoc to manage the operation of clinical drug trials focused on the treatment of PTSD with psychedelic therapy. Read more below!
Jinay (@jinaycodes) 's Twitter Profile Photo

Introducing soarXiv ✈️, the most beautiful way to explore human knowledge Take any paper's URL and replace arxiv with soarxiv (show in video) to teleport to its place in the universe I've embedded all 2.8M papers up until April 2025 Try it at: soarxiv dot org

Balázs Szigeti (@psybalazs) 's Twitter Profile Photo

I dislike the phrase "treatment-resistant depression" (TRD) as it does not define what treatment was resisted. Was it some SSRI? Psychedelic- assisted therapy (=PAT)? rTMS? We should be more specific and say SSRI / PAT / rTMS (etc.) resistant depression.

Psychedelics Today (@psydelicstoday) 's Twitter Profile Photo

Many psychedelic organizations (including us) have been shut down on META platforms yesterday. If your organization lost their account in the last 3 days, please put your information in here. forms.gle/3jy2xb1EFsRfJn…

Balázs Szigeti (@psybalazs) 's Twitter Profile Photo

We are now testing #psychedelics therapy for SSRI-resistant depression (i.e. patients who did not respond to #SSRIs before). But nobody is planning to run a trial on SSRIs for psychedelic-resistant depression (i.e. patients who did not respond to psychedelic-therapy before).

Leor Roseman 🦋 @leorroseman.bsky.social (@leorroseman) 's Twitter Profile Photo

New in Nature Medicine: ReSPCT "An international Delphi consensus for reporting of setting in psychedelic clinical trials" by Chloé Pronovost-Morgan, Kyle Greenway, myself, and many ReSPCT Experts. "The ReSPCT guidelines and accompanying explanatory document provide a new standard for

Balázs Szigeti (@psybalazs) 's Twitter Profile Photo

There is a real exciting DMT project proposed by Andrew Gallimore to be potentially funded by PsyDAO ... DMT + decentralized science just feels right in 2025! 💊👾👽🛸🔬💊👾👽🛸🔬 Come and hear the details at the event below! I (almost) already know which way I will vote😉

Balázs Szigeti (@psybalazs) 's Twitter Profile Photo

If you want to know how to solve the problem on the top, come to my talk at the bottom! I promise it will not be just 'lets try niacin'! 😉 (hope to) See you in Denver on June 19th from 10am! #PsychedelicScience2025 #PS2025

If you want to know how to solve the problem on the top, come to my talk at the bottom! I promise it will not be just 'lets try niacin'! 😉

(hope to) See you in Denver on June 19th from 10am! 
#PsychedelicScience2025 #PS2025
Robin Carhart-Harris (@rcarhartharris) 's Twitter Profile Photo

My comments in the thread might be interpreted otherwise but I admire this work. It’s so good to present surprising results and get the critical juices going… It’s how we learn…

Balázs Szigeti (@psybalazs) 's Twitter Profile Photo

OK, I have come around on this, instead of Psychedelic-assisted therapy, how about how about Therapy-assisted psychedelic? Gives more emphasis to the drug component of the treatment